PT  - JOURNAL ARTICLE
AU  - Carlton A. Richie III
AU  - William W. Briner
TI  - Corticosteroid Injection for Treatment of de Quervain’s Tenosynovitis: A Pooled Quantitative Literature Evaluation
AID  - 10.3122/jabfm.16.2.102
DP  - 2003 Mar 01
TA  - The Journal of the American Board of Family Practice
PG  - 102--106
VI  - 16
IP  - 2
4099  - http://www.jabfm.org/content/16/2/102.short
4100  - http://www.jabfm.org/content/16/2/102.full
SO  - J Am Board Fam Med2003 Mar 01; 16
AB  - Background: There have been many approaches described to treat de Quervain’s tenosynovitis, but no definite consensus emerges in the literature. We conducted a pooled quantitative literature evaluation to review the therapeutic studies in the English language to determine the various reported cure rates.Methods: All citations in the MEDLINE and Ovid databases that addressed de Quervain’s tenosynovitis were independently reviewed. Appropriate studies from the bibliographies of these articles were then obtained. Of the 35 articles on de Quervain’s temosynovitis that were found in the modern literature, only seven allowed for comparison among potentially effective treatments. Studies were included if they evaluated or compared treatment options among patients and had defined criteria for diagnosis and successful treatment. These seven studies were descriptive, not comparative. In other words, each study reported the proportion of successful outcomes with different treatments, without a comparison to a specified control group. Four hundred fifty-nine wrists were subjected to one of several therapeutic modalities.Results: There was an 83% cure rate with injection alone. This rate was much higher than any other therapeutic modality (61% for injection and splint, 14% for splint alone, 0% for rest or nonsteroidal anti-inflammatory drugs).Conclusion: It seems that injection alone is the best therapeutic approach to de Quervain’s tenosynovitis.